
IndraLab
Statements
sparser
"These different subtypes of ovarian cancer are associated with different molecular characteristics: high grade serous cancers typically contain TP53 mutations [ xref , xref ], low grade serous carcinomas often have RAS-RAF pathway activation and mutations in the KRAS and BRAF genes [ xref ], low-grade endometrioid cancers are associated with mutations in the beta-catenin gene, CTNNB1 [ xref ], and mucinous cancers frequently have mutations in KRAS [ xref ]."
sparser
"Although somatic mutation of CTNNB1 is rare in BC [ xref , xref ], mounting evidences have revealed that the somatic mutations in CTNNB1 are often associated with the upregulation of β-catenin and the pathogenesis of endometrioid-type of endometrial cancer and ovarian cancer [ xref , xref ]."
sparser
"The impairment of β-catenin signaling in Dox-treated HuH6sh CTNNB1 cells was associated with a substantial cell growth defect when cells were seeded at very low density (Additional file xref : Figure S1-A), whereas cell growth was not significantly affected when cells were seeded at medium density (Additional file xref : Figure S1-B)."
sparser
"We also examined the levels of key proteins involved in the cell cycle pathway (Cyclin D1:CCND1, Cyclin Dependent Kinase 1:CDK1, Cyclin Dependent Kinase 2:CDK2, Tumor Protein p53:TP53 and Catenin Beta 1:CTNNB1) at 24 and 48 h after CKI treatment previously shown to have altered transcript expression by CKI (Fig. xref b)."